Search results for "Secondary prevention"

No sex-specific differences seen in effectiveness, safety of aspirin for secondary prevention

Both men and women with atherosclerotic cardiovascular disease had similar rates of ischemic events on a daily aspirin dose of 81 mg versus 325 mg, according to a new analysis of an open-label randomized trial for secondary prevention.
https://immattersacp.org/weekly/archives/2024/07/16/4.htm
16 Jul 2024